Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Viking Thera (VKTX)

Viking Thera (VKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,465,013
  • Shares Outstanding, K 110,268
  • Annual Sales, $ 0 K
  • Annual Income, $ -85,900 K
  • 60-Month Beta 1.03
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 6.39
Trade VKTX with:

Options Overview Details

View History
  • Implied Volatility 119.87% ( -2.90%)
  • Historical Volatility 68.80%
  • IV Percentile 67%
  • IV Rank 51.03%
  • IV High 234.70% on 02/16/24
  • IV Low 0.20% on 02/27/24
  • Put/Call Vol Ratio 0.26
  • Today's Volume 15,051
  • Volume Avg (30-Day) 15,607
  • Put/Call OI Ratio 0.32
  • Today's Open Interest 211,230
  • Open Int (30-Day) 192,664

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.26
  • Number of Estimates 9
  • High Estimate -0.17
  • Low Estimate -0.33
  • Prior Year -0.19
  • Growth Rate Est. (year over year) -36.84%

Price Performance

See More
Period Period Low Period High Performance
1-Month
46.11 +24.01%
on 06/26/24
60.23 -5.06%
on 07/11/24
+4.72 (+9.00%)
since 06/12/24
3-Month
46.11 +24.01%
on 06/26/24
81.86 -30.15%
on 05/07/24
-11.44 (-16.67%)
since 04/12/24
52-Week
8.28 +590.58%
on 10/26/23
99.41 -42.48%
on 02/28/24
+41.79 (+271.54%)
since 07/12/23

Most Recent Stories

More News
Is Viking Therapeutics Stock Running Out of Steam?

Viking's stock has tripled in less than a year, and its red-hot valuation could have investors thinking twice about buying it today.

VKTX : 57.18 (-2.47%)
Better GLP-1 Biotech Stock: Altimmune vs. Viking Therapeutics

Both competitors have promising lead programs, and enough cash, too.

LLY : 948.40 (+1.53%)
ALT : 7.90 (+2.86%)
VKTX : 57.18 (-2.47%)
Eli Lilly Rose More Than 50% So Far This Year. Can It Soar Past $1,000 in the 2nd Half?

This pharma company is posting double-digit revenue growth.

GS : 479.88 (+0.14%)
NVO : 142.08 (+1.64%)
AMGN : 330.83 (+1.77%)
VKTX : 57.18 (-2.47%)
LLY : 948.40 (+1.53%)
Forget Eli Lilly: 3 Biotech Stocks to Buy Instead

Eli Lilly is a good stock to buy, but these should be even better.

LLY : 948.40 (+1.53%)
AMGN : 330.83 (+1.77%)
VRTX : 488.74 (-0.69%)
VKTX : 57.18 (-2.47%)
Viking Therapeutics Stock Is Up by 154% Since January -- Can It Double Again in the Second Half of the Year?

It's a tough act to follow.

LLY : 948.40 (+1.53%)
VKTX : 57.18 (-2.47%)
3 Reasons Why Altimmune Stock Could Be the Next Viking Therapeutics

While their share prices have traveled different paths recently, the similarity between the two companies is striking.

LLY : 948.40 (+1.53%)
MS : 104.09 (-0.53%)
ALT : 7.90 (+2.86%)
VKTX : 57.18 (-2.47%)
Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030

These healthcare stocks have clear paths to growth over the next few years.

LLY : 948.40 (+1.53%)
NVO : 142.08 (+1.64%)
VRTX : 488.74 (-0.69%)
VKTX : 57.18 (-2.47%)
TMDX : 142.19 (-1.21%)
Stocks Finish Slightly Higher on Fed Optimism

The S&P 500 Index ($SPX ) (SPY ) Thursday closed up +0.09%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.09%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.19%. Stock indexes recovered...

$SPX : 5,615.35 (+0.55%)
SPY : 559.99 (+0.63%)
$DOWI : 40,000.90 (+0.62%)
DIA : 400.32 (+0.68%)
$IUXX : 20,331.49 (+0.59%)
QQQ : 494.82 (+0.59%)
ZNU24 : 111-060s (+0.03%)
ZS : 201.90 (+3.05%)
PANW : 336.50 (+1.65%)
FTNT : 59.55 (+1.29%)
CRWD : 371.32 (+0.24%)
WBA : 11.50 (+0.61%)
Stocks Mixed After This Morning's Fed-Friendly US Economic Reports

The S&P 500 Index ($SPX ) (SPY ) today is down -0.19%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.11%. Stock indexes today are mixed...

$SPX : 5,615.35 (+0.55%)
SPY : 559.99 (+0.63%)
$DOWI : 40,000.90 (+0.62%)
DIA : 400.32 (+0.68%)
$IUXX : 20,331.49 (+0.59%)
QQQ : 494.82 (+0.59%)
ZNU24 : 111-060s (+0.03%)
MU : 133.55 (+2.55%)
NVDA : 129.24 (+1.44%)
ON : 76.87 (+3.54%)
GFS : 54.48 (+2.91%)
MCHP : 92.61 (+0.56%)
Stocks Pressured by Negative Corporate News

The S&P 500 Index ($SPX ) (SPY ) today is down -0.03%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.10%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.05%. Stock indexes today are mixed....

$SPX : 5,615.35 (+0.55%)
SPY : 559.99 (+0.63%)
$DOWI : 40,000.90 (+0.62%)
DIA : 400.32 (+0.68%)
$IUXX : 20,331.49 (+0.59%)
QQQ : 494.82 (+0.59%)
ZNU24 : 111-060s (+0.03%)
MU : 133.55 (+2.55%)
NVDA : 129.24 (+1.44%)
ON : 76.87 (+3.54%)
GFS : 54.48 (+2.91%)
MCHP : 92.61 (+0.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Weakest short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Viking Therapeutics, Inc. is a biopharmaceutical company. The company is engaged in development of novel therapies for metabolic and endocrine disorders. Its product candidate consists of VK5211, VK0214, VK0612 and VK2809 which are in different clinical trial. Viking Therapeutics, Inc. is based in LA...

See More

Key Turning Points

3rd Resistance Point 61.60
2nd Resistance Point 60.69
1st Resistance Point 58.94
Last Price 57.18
1st Support Level 56.28
2nd Support Level 55.37
3rd Support Level 53.62

See More

52-Week High 99.41
Fibonacci 61.8% 64.60
Last Price 57.18
Fibonacci 50% 53.85
Fibonacci 38.2% 43.09
52-Week Low 8.28

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar